0001844030-21-000002.txt : 20210204
0001844030-21-000002.hdr.sgml : 20210204
20210203181041
ACCESSION NUMBER: 0001844030-21-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210204
DATE AS OF CHANGE: 20210203
EFFECTIVENESS DATE: 20210204
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Exacis Biotherapeutics Inc.
CENTRAL INDEX KEY: 0001844030
IRS NUMBER: 852959151
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-388374
FILM NUMBER: 21587733
BUSINESS ADDRESS:
STREET 1: 1035 CAMBRIDGE STREET
STREET 2: SUITE 17B
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: 1 917 415 3000
MAIL ADDRESS:
STREET 1: 1035 CAMBRIDGE STREET
STREET 2: SUITE 17B
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
D
1
primary_doc.xml
X0708
D
LIVE
0001844030
Exacis Biotherapeutics Inc.
1035 CAMBRIDGE STREET
SUITE 17B
CAMBRIDGE
MA
MASSACHUSETTS
02141
1 917 415 3000
DELAWARE
None
None
Corporation
true
2020
Gregory
Fiore
1035 Cambridge Street
Suite 17B
Cambridge
MA
MASSACHUSETTS
02141
Executive Officer
Chief Executive Officer
Matthew
Angel
1035 Cambridge Street
Suite 17B
Cambridge
MA
MASSACHUSETTS
02141
Director
Mark
Corrigan
1035 Cambridge Street
Suite 17B
Cambridge
MA
MASSACHUSETTS
02141
Director
Biotechnology
Decline to Disclose
- 06b
false
2021-01-22
false
true
Convertible Note
false
25000
3000000
50000
2950000
false
1
0
0
0
false
Exacis Biotherapeutics Inc.
/s/ Gregory Fiore
Gregory Fiore
Chief Executive Officer
2021-02-03